Atlas Trials

Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19

Clinical trial NCT04498936 · COMPLETED

Trial details

NCT number
NCT04498936
Sponsor
Assiut University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID
Start date
2020-07-15
Primary completion
2020-10-30
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.